返回 Agendas
The Role of Innovation in Clinical Trial Advocacy: Developing and Executing Patient-Centered Strategies and Partnerships Throughout the Continuum
Session Chair(s)
Lisa Palladino-Kim, EdD, MS
Lecturer / Director of Capstone
Rutgers School of Health Professions Clin Research Mgmt, United States
Industry is embracing the importance of diversifying the clinical trial patient population in an increasingly challenging recruitment landscape. The pharmaceutical industry's involvement with patient groups has historically focused on one-way communications, typically offering short-term results. A combination of new media and strategic communications leads to richer community engagement and increased responses.
Learning Objective : Demonstrate the role of patient-centered strategies in overcoming challenges and identifying opportunities that impact a drug’s development; Describe the importance of strategic partnerships; Apply best practices learned from innovative educational campaigns; Discuss how to spring-board the voice of patients into the development of clinical trials.
Speaker(s)
Clinical Trial Advocacy: Developing and Executing Advocacy Strategies from Discovery Through Drug Development
Mary Murray, MBA, MS
Independent Consultant, United States
Family Caregiver
Patient Advocate Perspective
Andrea Stern Ferris, MBA
LUNGevity Foundation, United States
President and CEO
Activating Patients for Clinical Trials Through Meaningful Education and Advocacy
Kristin Voorhees, MA
Ultragenyx, United States
Director, Patient Advocacy